SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after receiving FDA Fast Track designation for sonelokimab in palmoplantar pustulosis, a development the community views as a major de-risking catalyst. Despite this positive news, many are actively discussing perceived market manipulation, believing the stock is undervalued and anticipating significant updates on clinical data and strategic direction at the upcoming Investor Day.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space is trending as its IPO quiet period concludes and investors await potential news regarding an FAA Space Launch license, fueling community debate over its tiny float and high short interest, particularly amidst broader speculation for the upcoming Space X IPO.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending following a challenging Q4 earnings report that revealed declining U.S. sales and a weak 2026 outlook, leading to analyst downgrades and high short interest. Community discussion is split between concerns over the company's debt, potential dividend cuts, and ongoing CEO search versus optimism for a turnaround, short squeeze, or potential buyout at its current low valuation.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera (ATOM) is trending due to recent earnings call comments from its CEO, fueling speculation that its Mears Silicon Technology (MST) is making significant progress with major chipmakers for Gate-All-Around and DRAM, alongside breakthroughs in GaN-on-Silicon for AI and data centers. The community is actively debating whether record trading volumes and increased management accountability signal a long-awaited valuation reset for the pre-revenue semiconductor innovator.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as its AXPAXLI drug successfully met the primary endpoint in the SOL-1 Phase 3 trial for wet AMD, demonstrating superiority over Eylea and offering a reduced treatment burden. Despite these positive results, the stock saw a significant sell-off driven by market concerns over the efficacy margin and control arm performance, sparking widespread debate among investors whether the reaction is an overcorrection or a fundamental reassessment.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is experiencing intense debate following impressive Q2 earnings and strong guidance, attributed to surging demand for its optical components in AI data centers. Bulls are celebrating its significant run as a critical AI infrastructure play, while bears vigorously argue it's extremely overvalued and due for a sharp correction.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion Inc. ($INFQ) is seeing significant attention as it begins trading after its SPAC merger, positioning itself as a leader in neutral-atom quantum technology. The community is highly optimistic, emphasizing its undervalued status compared to competitors, major partnerships with entities like NVIDIA and NASA, and real-world defense contracts driving long-term growth potential.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending after Hapag-Lloyd confirmed an agreement to acquire the shipping company for $35 per share in an all-cash deal. The community is actively discussing the arbitrage opportunity, the stock's trading discount to the buyout price, and perceived risks related to regulatory approvals, geopolitical factors, and potential dividends before the expected late 2026 deal close.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is actively discussed ahead of its earnings report, with community sentiment split between concerns that AI could disrupt cybersecurity and the belief that AI-powered solutions, like those from its significant Google Cloud partnership and recent acquisitions, will drive increased demand in the sector.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending following robust Phase 2 data for its NXC-201 CAR-T therapy in AL Amyloidosis, prompting an upsized institutional offering and fueling community discussions of a potential buyout or short squeeze. The therapy's strong efficacy and safety profile, alongside its broader potential in autoimmune conditions, positions it as a significant long-term value play.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026

Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026 Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026 PR Newswire HOLON...

Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors

Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors PR Newswire HOLON...

Compugen (NASDAQ:CGEN) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell?

Compugen (NASDAQ:CGEN) Stock Price Crosses Above 200 Day Moving Average - Should You Sell...

Compugen (NASDAQ:CGEN) Stock Price Passes Above 200 Day Moving Average - What's Next?

Compugen (NASDAQ:CGEN) Stock Crosses Above 200-Day Moving Average - Time to Sell...

Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million

Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million PR...

Compugen (NASDAQ:CGEN) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded Compugen from a "sell" rating to a "hold" rating in a research report on Saturday...

Analysts Set Expectations for Compugen FY2025 Earnings

Compugen Ltd. (NASDAQ:CGEN - Free Report) - Equities researchers at Leerink Partnrs increased their FY2025 earnings per share estimates for Compugen in a research report issued on Monday, November...

FY2025 EPS Estimates for Compugen Lifted by Leerink Partnrs

Compugen Ltd. (NASDAQ:CGEN - Free Report) - Investment analysts at Leerink Partnrs raised their FY2025 earnings per share estimates for shares of Compugen in a research note issued on Monday...

Compugen (NASDAQ:CGEN) Issues Quarterly Earnings Results

Compugen (NASDAQ:CGEN - Get Free Report) released its quarterly earnings results on Monday. The biotechnology company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts...

Compugen (CGEN) Reports Q3 Loss, Lags Revenue Estimates

Compugen (CGEN) delivered earnings and revenue surprises of +22.22% and -14.43%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.

Compugen Ltd

Fundamental

Technical

A mix of both

Some investors focus on company fundamentals like earnings, growth, and valuation. Others rely on price action, trends, and momentum. Many use a combination of both to guide their decisions. What do you use?

What type of analysis drives your investment decisions?

CGEN
Compugen Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CGEN News

CGENCompugen Ltd